Earnings Growth Forecast: 54.3% p.a.

Redcare Pharmacy is poised for significant growth, with revenue expected to increase by 17.5% annually, outpacing the broader German market. Despite a low forecasted return on equity of 14.1%, the company is set to become profitable within three years, surpassing average market growth rates. Recent insider activity shows more buying than selling in the past three months. The company raised its sales guidance for 2024 to between €2.35 billion and €2.5 billion, indicating robust performance expectations despite past shareholder dilution and recent losses.

• Click here and access our complete growth analysis report to understand the dynamics of Redcare Pharmacy.

• The analysis detailed in our Redcare Pharmacy valuation report hints at an inflated share price compared to its estimated value.

Zalando

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Zalando SE operates an online platform for fashion and lifestyle products with a market cap of approximately €7.81 billion.

Operations: The company's revenue segments include a Segment Adjustment of €10.49 billion, excluding reconciliation amounts.

Insider Ownership: 10.4%

Earnings Growth Forecast: 24.4% p.a.

Zalando's earnings have surged by 84.3% over the past year, with forecasts suggesting a 24.4% annual growth rate, surpassing the German market average of 19.9%. Despite trading at a significant discount to its estimated fair value, its Return on Equity is projected to be modest at 12.8% in three years. Recent executive changes include CFO Dr. Sandra Dembeck's departure by February 2025, while Q2 sales rose to €2.64 billion from €2.56 billion year-on-year, reflecting solid performance momentum.

• Unlock comprehensive insights into our analysis of Zalando stock in this growth report.

• Our valuation report unveils the possibility Zalando's shares may be trading at a premium.

Make It Happen

• Click through to start exploring the rest of the 19 Fast Growing German Companies With High Insider Ownership now.

• Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance.

• Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets.

Want To Explore Some Alternatives?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.

• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.

• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Companies discussed in this article include XTRA:HYQ XTRA:RDC and XTRA:ZAL.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]